News
![](https://www.yposkesi.com/wp-content/uploads/2023/03/Featured-image-AAV-manufacturing-platform-page.png)
Yposkesi launches AAVelocity™, a plug-and-play Adeno-Associated Virus (AAV) platform
7 November 2023![](https://www.yposkesi.com/wp-content/uploads/2023/09/SK-CBM.png)
SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines
20 September 2023![](https://www.yposkesi.com/wp-content/uploads/2023/05/Article-timelapse.png)
Yposkesi inaugurates €60M biomanufacturing site for cell and gene therapies
22 June 2023Blog
![](https://www.yposkesi.com/wp-content/uploads/2023/10/Triton-X-100-poster-article.png)
Case Study: Evaluation of several process cell lysis reagents as replacements for Triton X-100 for rAAV production.
14 November 2023![](https://www.yposkesi.com/wp-content/uploads/2023/10/BioInsights-podcast-2023.png)
Podcast: Building with the patient in mind: Designing a state-of-the-art facility for viral vector manufacturing
13 October 2023![](https://www.yposkesi.com/wp-content/uploads/2023/10/Featured-images-website.png)